U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 10-QSB
                                   (Mark One)

    [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
                                   ACT OF 1934

                  For the quarterly period ended March 31, 2006

       [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

                        For the transition period from to

                         Commission File Number: 0-27445

                        Enviro Voraxial Technology, Inc.
                        --------------------------------
        (Exact name of Small Business Issuer as specified in its Charter)

                   IDAHO                                         82-0266517
                   -----                                         ----------
    (State or other jurisdiction of                          (I.R.S. Employer
     incorporation or organization)                         Identification No.)


                821 NW 57th Place, Fort Lauderdale, Florida 33309
                -------------------------------------------------
                    (Address of principal executive offices)

                                 (954) 958-9968
                                 --------------
                           (Issuer's telephone number)

                   ------------------------------------------
              (Former Name, former address and former fiscal year,
                         if changed since last Report.)

Check mark whether the Issuer (1) has filed all reports required to be filed by
Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. Yes [X]     No [ ]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).  Yes [ ]      No [X]

                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: March 31, 2006, we had 19,864,735
shares of our Common Stock outstanding.

Transitional Small Business Disclosure Format (Check one): Yes [ ]    No [X]


<PAGE>
<TABLE>
<CAPTION>
                                      INDEX


<S>          <C>                                                                                         <C>
PART I.      CONSOLIDATED CONDENSED FINANCIAL INFORMATION

Item 1.      Consolidated Condensed Financial Statements..............................................    3

             Condensed Consolidated Balance Sheet - March 31, 2006 (Unaudited)........................    3

             Condensed Consolidated Statements of Operations for the
                Three Months Ended March 31, 2006 and 2005 (Unaudited)................................    4

             Condensed Consolidated Statements of Cash Flows for the
                Three Months Ended March 31, 2006 and 2005 (Unaudited)................................    5

             Notes to Condensed Consolidated Financial Statements (Unaudited).........................    6

Item 2.      Management's Discussion and Analysis and Plan of
                Operation.............................................................................    9

Item 3.      Controls and Procedures..................................................................    11


PART II.     OTHER INFORMATION

Item 1.      Legal Proceedings........................................................................    11
Item 2.      Unregistered Sales of Equity Securities and Use of Proceeds..............................    11
Item 3.      Default Upon Senior Securities...........................................................    12
Item 4.      Submission of Matters to a Vote of Securities............................................    12
Item 5.      Other Information........................................................................    12
Item 6.      Exhibits.................................................................................    12

Signatures   .........................................................................................    13
</TABLE>























                                       2
<PAGE>
PART I. CONSOLIDATED FINANCIAL INFORMATION
------------------------------------------

Item 1.  Financial Statements.
<TABLE>
<CAPTION>
              ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                    CONDENSED CONSOLIDATED BALANCE SHEET

                                                                                        March 31,
                                                                                           2006
                                                                                     ----------------
                                                                                       (Unaudited)
<S>                                                                                         <C>
                                   ASSETS

CURRENT ASSETS:
      Cash and cash equivalents                                                      $        161,085
      Accounts receivable                                                                      22,164
      Inventory                                                                               137,022
      Prepaid expenses                                                                         26,991
                                                                                     ----------------

        Total current assets                                                                  347,262

 FIXED ASSETS, NET                                                                              5,191

 OTHER ASSETS                                                                                  10,000
                                                                                     ----------------

    Total assets                                                                     $        362,453
                                                                                     ================

                  LIABILITIES AND SHAREHOLDERS' DEFICIENCY

 CURRENT LIABILITIES:
       Accounts payable and accrued expenses                                         $        533,000
       Customer deposits                                                                       78,750
                                                                                     ----------------

        Total current liabilities                                                             611,750
                                                                                     ----------------


        Total liabilities                                                                     611,750
                                                                                     ----------------
 COMMITMENTS AND CONTINGENCIES

 SHAREHOLDERS' DEFICIENCY:
 Common stock, $.001 par value, 42,750,000 shares authorized
      19,864,735 shares issued and oustanding                                                  19,864
 Additional paid-in capital                                                                 5,870,938
 Deferred compensation                                                                        (41,375)
 Accumulated deficit                                                                       (6,098,724)
                                                                                     ----------------

        Total shareholders' deficiency                                                       (249,297)
                                                                                     ----------------

 Total liabilities and shareholders' deficiency                                      $        362,453
                                                                                     ================
</TABLE>




               The accompanying notes are an integral part of the
                       consolidated financial statements.
                                       3
<PAGE>
<TABLE>
<CAPTION>
                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                     CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



                                                                               Three Months Ended March 31,
                                                                    --------------------------------------------------
                                                                            2006                          2005
                                                                    ---------------------        ---------------------
                                                                         (Unaudited)                  (Unaudited)
<S>                                                                 <C>                          <C>
Revenues, net                                                       $             22,164         $                  --

Cost of goods sold                                                                 4,778                            --
                                                                    --------------------         ---------------------

Gross Profit                                                                      17,386                            --

Costs and expenses:
      General and administrative                                                  88,409                       125,000
      Research and development                                                   145,696                       119,000
                                                                    --------------------         ---------------------

                Total costs and expenses                                         234,105                       244,000
                                                                    --------------------         ---------------------

Loss from operations                                                            (216,719)                     (244,000)
                                                                    --------------------         ---------------------

NET LOSS                                                            $           (216,719)        $            (244,000)
                                                                    ====================         =====================

Weighted average number of common shares
   outstanding-basic & diluted                                                19,622,797                    17,676,402
                                                                    ====================         =====================

Basic and diluted loss per common share                             $              (0.01)        $               (0.01)
                                                                    ====================         =====================
</TABLE>













               The accompanying notes are an integral part of the
                       consolidated financial statements.

                                       4

<PAGE>
<TABLE>
<CAPTION>
                 ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                For the Three Months Ended March 31,
                                                                            ---------------------------------------------
                                                                                    2006                   2005
                                                                            --------------------   ----------------------
                                                                                (Unaudited)             (Unaudited)
<S>                                                                         <C>                    <C>
Cash Flows From Operating Activities:
Net loss                                                                    $           (216,719)  $            (244,000)
Adjustments to reconcile net loss to net
cash used by operating activities:
  Depreciation                                                                               147                   2,000
  Common stock issued for services                                                        40,000                      --
  Amortization of deferred compensation                                                       --                  16,000
  Deferred compensation                                                                   12,062                      --
Changes in assets and liabilities:
  Accounts receivable                                                                    (22,164)                     --
  Inventory                                                                              (10,988)                (47,000)
  Prepaid insurance                                                                      (26,991)                (22,000)
  Accounts payable and accrued expenses                                                  108,297                  73,000
  Deposits from customers                                                                 78,750                  48,000
                                                                            --------------------   ---------------------

Net cash used in operating activities                                                    (37,606)               (174,000)
                                                                            --------------------   ---------------------

Cash Flows From Investing Activities:
   Purchase of equipment                                                                      --                  (6,000)
                                                                            --------------------   ---------------------

Net cash provided by investing activities                                                     --                  (6,000)
                                                                            --------------------   ---------------------

Cash Flows From Financing Activities:
   Proceeds from sales of common stock                                                   122,000                      --
                                                                            --------------------   ---------------------

Net cash provided by financing activities                                                122,000                      --
                                                                            --------------------   ---------------------

Net increase (decrease) in cash and cash equivalents                                      84,394                (180,000)

Cash and cash equivalents, beginning of period                                            76,691                 221,000
                                                                            --------------------   ---------------------

Cash and cash equivalents, end of period                                    $            161,085   $              41,000
                                                                            ====================   =====================
Supplemental Disclosures

  Cash paid during the year for interest                                    $                 --   $                  --
                                                                            ====================   =====================
  Cash paid during the year for taxes                                       $                 --   $                  --
                                                                            ====================   =====================
  Common stock issued for deferred consulting                               $                 --   $                  --
                                                                            ====================   =====================
  Common stock issued for consulting services                               $             40,000   $                  --
                                                                            ====================   =====================
</TABLE>








               The accompanying notes are an integral part of the
                       consolidated financial statements.

                                       5
<PAGE>
NOTE A - ORGANIZATION AND OPERATIONS

Organization
------------
Enviro Voraxial Technology, Inc. (the "Company") is a provider of environmental
and industrial separation technology. The Company has developed and patented the
Voraxial(R) Separator, which is a technology that efficiently separates solids
and liquids with distinct specific gravities. Potential commercial applications
and markets include oil exploration and production, pre-treatment of wastewater
at municipal wastewater (headworks) facilities, oil and water separation, and
environmental cleanup.

Since 1999, the Company has been focusing its efforts on developing and
marketing the Voraxial(R) Separator. The Company currently operates within two
segments: the sales and marketing of the Voraxial(R) Separator and the
manufacture of the Voraxial(R) Separator.

Florida Precision Aerospace, Inc. (FPA) is the wholly-owned subsidiary of the
Company and is used to do contract work with the aerospace, automotive and
defense contracting activity.

In March 2006, a Voraxial(R) 4000 Separator was sold to ConocoPhillips for
produced water separation. The machine will be used to enhance the handling of
large volumes of produced water and water injection at a production facility.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation
---------------------------
The consolidated financial statements include the accounts of the parent
company, Enviro Voraxial Technology, Inc., and its wholly-owned subsidiary,
Florida Precision Aerospace, Inc. All significant intercompany accounts and
transactions have been eliminated.

Interim Financial Statements
----------------------------
The interim financial statements presented herein have been prepared pursuant to
the rules and regulations of the Securities and Exchange Commission ("SEC").
Certain information and footnote disclosures normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America have been condensed or omitted pursuant to such
rules and regulations. The interim financial statements should be read in
conjunction with the Company's annual financial statements, notes and accounting
policies included in the Company's annual report on Form 10-KSB for the year
ended December 31, 2005 as filed with the SEC. In the opinion of management, all
adjustments (consisting only of normal recurring adjustments) which are
necessary to provide a fair presentation of financial position as of March 31,
2006 and the related operating results and cash flows for the interim period
presented have been made. The results of operations, for the period presented
are not necessarily indicative of the results to be expected for the year.

Use of Estimates
----------------
Use of estimates and assumptions by management is required in the preparation of
financial statements in conformity with generally accepted accounting
principles. Actual results could differ from those estimates and assumptions.

Earnings Per Share
------------------
Basic earnings per share ("EPS") is computed by dividing earnings available to
common shareholders by the weighted-average number of common shares outstanding
                                       6
<PAGE>
for the period as required by the Financial Accounting Standards Board (FASB)
under Statement of Financial Accounting Standards (SFAS) No. 128, "Earnings per
Shares". Diluted EPS reflects the potential dilution of securities that could
share in the earnings.

NOTE C - CAPITAL TRANSACTIONS

Common stock
------------
In January 2006, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 243,200 shares of common stock
issued in 2000 for a period of one year. The warrants now expire in February
2007.

In January 2006, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 200,000 shares of common stock
issued in 2001 for a period of one year. The warrants now expire in April 2007.

In January 2006, the Company issued 100,000 shares of common stock to a
consultant, valued at $40,000, which is based on the closing market price of the
Company's common stock on the date of the agreement.

During the three months ended March 31, 2006 the Company sold 305,000 shares of
common stock for $0.40 per share in a private placement offering. Total proceeds
from the sale were $122,000.

Options
-------
Information with respect to employee stock options outstanding and employee
stock options exercisable at March 31, 2006 is as follows:
<TABLE>
<CAPTION>
                                                                                           Weighted Average
                                       Options          Vested       Exercise Price Per   Exercise Price Per
                                     Outstanding        Shares          Common Share      Option Outstanding
                                     -----------        ------          ------------      ------------------
<S>                                   <C>              <C>              <C>   <C>               <C>
Balance, December 31, 2002            2,245,000        1,115,000        $0.15-$0.77             $0.21
Granted/vested during the year           10,000        1,120,000              $1.00

Balance, December 31, 2002            2,245,000        2,235,000        $0.15-$1.00             $0.21
Granted/vested during the year        1,424,666        1,424,666        $0.15-$1.00             $0.79

Balance, December 31, 2004            3,679,666        3,659,666        $0.15-$1.00             $0.52

Granted/vested during the year           50,000           50,000              $1.00
Balance, December 31, 2005            3,729,666        3,709,666        $0.15-$1.00             $0.52

Granted/vested during the quarter
                                              -                -                  -                 -
Balance, March 31, 2006               3,729,666        3,709,666        $0.15-$1.00             $0.52
</TABLE>






                                       7
<PAGE>
The following tables summarize information about the stock options and warrants
outstanding at March 31, 2006:

Options
-------
<TABLE>
<CAPTION>
                                          Weighted Average      Weighted           Number
     Exercise        Number Outstanding       Remaining          Average       Exercisable at     Weighted Average
       Price          at March 31, 2006   Contractual Life   Exercise Price    March 31, 2006      Exercise Price
       -----          -----------------   ----------------   --------------    --------------      --------------
<S>    <C>                  <C>                  <C>               <C>              <C>                 <C>
       0.30                 45,000               0.87              0.30             45,000              0.30
       0.77                200,000               1.13              0.77            200,000              0.77
       0.15              2,000,000               1.55              0.15          2,000,000              0.15
       1.00                 10,000               1.00              1.00             10,000              1.00
       0.60                697,333               3.13              0.60            697,333              0.60
       1.00                697,333               3.13              1.00            697,333              1.00
       1.00                 50,000               3.00              1.00             50,000              1.00
       0.71                 30,000               1.17              0.71             30,000              0.71
                         ---------                                               ---------
                         3,729,666                                               3,729,666
                         =========                                               =========
</TABLE>
Warrants
--------
<TABLE>
<CAPTION>
                                                                   Number      Range of Exercise        Number
                                                                Outstanding          Price           Exercisable
                                                                -----------          -----           -----------
<S>                                                              <C>                      <C>           <C>
Balance - December 31, 2002                                      1,477,200        $1.00 - $9.00         1,477,200
Issued                                                           1,585,002                $1.00         1,385,002
                                                                 ---------                              ---------

Balance, December 31, 2003                                       3,062,202        $1.00 - $9.00         2,862,202
Issued                                                           2,527,165        $0.75 - $1.00         2,527,165
                                                                 ---------                              ---------

Balance, December 31, 2004                                       5,589,367        $0.75 - $9.00         5,389,367
Issued                                                                  --                   --                --
                                                                 ---------        -------------         ---------

Balance, December 31, 2005                                       5,589,367        $0.75 - $9.00         5,389,367
Issued                                                                  --                   --                --
                                                                 ---------        -------------         ---------

Balance, March 31, 2006                                          5,589,367        $0.75 - $9.00         5,389,367
                                                                 ---------        -------------         ---------
</TABLE>
NOTE D - SUBSEQUENT EVENTS

Subsequent to March 31, 2006 the Company sold 415,000 shares of common stock for
$.40 per share in a private placement offering. Total proceeds from the sale
were $166,000.










                                       8
<PAGE>
Item 2. Management's Discussion and Analysis of Financial Condition and Plan of
        Operations

General

Forward-Looking Statements

The following discussion of the financial condition and results of operations
should be read in conjunction with our consolidated financial statements and
related notes thereto. The following discussion contains forward-looking
statements. Enviro Voraxial(R) Technology is referred to herein as "the
Company", "we" or "our." The words or phrases "would be," "will allow," "intends
to," "will likely result," "are expected to," "will continue," "is anticipated,"
"estimate," "project," or similar expressions are intended to identify
"forward-looking statements". Such statements include those concerning our
expected financial performance, our corporate strategy and operational plans.
Actual results could differ materially from those projected in the
forward-looking statements as a result of a number of risks and uncertainties.
Statements made herein are as of the date of the filing of this Form 10-QSB with
the Securities and Exchange Commission and should not be relied upon as of any
subsequent date. Unless otherwise required by applicable law, we do not
undertake, and we specifically disclaim any obligation, to update any
forward-looking statements to reflect occurrences, developments, unanticipated
events or circumstances after the date of such statement.

Application of Critical Accounting Policies

The Company's consolidated condensed financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of
America. Certain accounting policies have a significant impact on amounts
reported in the financial statements. A summary of these significant accounting
policies can be found in Note B to the Company's financial statements in the
Company's 2005 Annual Report on Form 10-KSB. The Company has not adopted any
significant new policies during the quarter ended March 31, 2006.

Among the significant judgments made in preparation of the Company's financial
statements are the determination of the allowance for doubtful accounts and
adjustments of inventory valuations. These adjustments are made each quarter in
the ordinary course of accounting.

Results of Operations for the Three Months ended March 31, 2006 and 2005:

Revenue

Our revenues were $22,164 for the three months ended March 31, 2006 as compared
to $-0- for the three months ended March 31, 2005. The revenues were from the
sale of Voraxial equipment parts for approximately $11,000 and the lease of a
Voraxial Separator for approximately $11,000. The Company continues to focus on
its sales and marketing program for the Voraxial(R) Separator and management
believes such efforts will result in increasing revenues in 2006.

Research and Development Expenses

Research and Development expenses increased by 22% to $145,696 for the three
months ended March 31, 2006, as compared to $119,000 for the previous three
months ended March 31, 2005. Although the Company has finalized the development
of the Voraxial(R) Separator, we targeted expenditures for specific applications
for the technology within the oil industry during the three months ended March
31, 2006.

                                       9
<PAGE>
General and Administrative Expenses

General and Administrative expenses decreased by 29% to $88,409 for the three
months ended March 31, 2006 down from $125,000 for the three months ended March
31, 2005. The decrease was primarily due to a decreases in overall general and
administrative expenses. We continue to focus our efforts on marketing of the
Voraxial Separator.

Liquidity and Capital Resources:

Cash at March 31, 2006 was $161,085. Working capital deficit at March 31, 2006
was $264,488 as compared to a working capital deficit at December 31, 2005 of
$221,978. The increase in the working capital deficit was primarily due to an
increase in customer deposits of $78,750 and increase in accounts payable and
accrued expenses of $108,297. These amounts were partially offset by a $84,394
increase in cash. The customer deposit is from a purchase order from
ConocoPhillips for a Voraxial Separator. The Company expects to deliver the
Voraxial Separator by July 2006.

At March 31, 2006 the Company had an accumulated deficit of $6,098,724. We
anticipate generating positive cash flow from the Voraxial(R) Separator by the
end of 2006. To the extent such revenues and corresponding cash flows do not
materialize, we will require an infusion of capital to sustain our operations.
We cannot be assured that we will generate revenues or that the level of any
future revenues will be self sustaining. Furthermore, we cannot provide any
assurances that required capital will be obtained or that terms of such required
capital may be acceptable to us.

The Company has funded working capital requirements and intends to fund current
working capital requirements through third party financing, including the
private placement of securities. However, the Company cannot provide any
assurances that it will be able to obtain adequate financing. If the Company is
unable to obtain adequate financing, it may reduce its operating activities
until sufficient funding is secured or revenues are generated to support
operating activities. During the period covered by this report, the Company
received $122,000 from seven accredited investors that purchased an aggregate of
305,000 shares of the Company's restricted common stock at $0.40 per share.
Subsequent to the period covered by this report, the Company sold an aggregate
of 415,000 shares of its common stock to six investors and received proceeds of
$166,000. Such proceeds will be used to fund working capital requirements.

Continuing Losses

We may be unable to continue as a going concern, given our limited operations
and revenues and our significant losses to date. Since 2001, we have encountered
greater expenses in the development of our Voraxial(R) Separators and have had
limited sales income from this development. Consequently, our working capital
may not be sufficient and our operating costs may exceed those experienced in
our prior years. In light of these recent developments, we may be unable to
continue as a going concern. However, we believe that the exposure received in
the past year for the Voraxial Separator has positioned the Company to begin
generating sales and supply us with sufficient working capital. As a result of
the above, the accompanying condensed consolidated financial statements have
been prepared assuming that the Company will continue as a going concern. The
condensed consolidated financial statements do not include any adjustments that
might result from the outcome of this uncertainty.






                                       10
<PAGE>
Item 3.  Controls and Procedures

Evaluation of disclosure controls and procedures

As of the end of the period covered by this report, we carried out an evaluation
of the effectiveness of the design and operation of our disclosure controls and
procedures pursuant to Exchange Act Rule 13a-15(e). This evaluation was done
under the supervision and with the participation of our Principal Executive
Officer and Principal Financial Officer. Based upon that evaluation, our
Principal Executive Officer and Principal Financial Officer concluded that our
disclosure controls and procedures are effective in gathering, analyzing and
disclosing information needed to satisfy our disclosure obligations under the
Exchange Act.

Changes in internal controls

There were no changes in our internal controls or in other factor during the
period covered by this report that have materially affected, or is likely to
materially affect the Company's internal controls over financial reporting.

                           PART II. OTHER INFORMATION

Item 1.  Legal Proceedings

         None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

         In January 2006, the Company entered into a six month consulting
agreement and agreed to issue 100,000 shares for services performed by a
consultant, which were valued at $40,000. The shares were issued pursuant to the
exemption from registration under Section 4(2) of the Securities Act. The
consultant received information concerning the Company and had the opportunity
to ask questions concerning the Company. The shares issued contain a legend
restricting transferability absent registration or applicable exemption.

         During the three month period ended March 31 2006, the Company received
$122,000 from seven accredited investors, including the Company's executive vice
president, that purchased an aggregate of 305,000 shares of the Company's
restricted common stock at $0.40 per share. The issuances were exempt from
registration under Section 4(2) of the Securities Act. The investors received
information concerning the Company and had the opportunity to ask questions
concerning the viability of the Company. The shares contain legends restricting
their transferability absent registration or applicable exemption.

         In January 2006, the Company extended the exercisable life of certain
warrants issued to investors to purchase an aggregate of 243,200 shares of
common stock issued in 2000 for a period of one year. The warrants now expire in
February 2007.

         In January 2006, the Company extended the exercisable life of certain
warrants issued to investors to purchase an aggregate of 200,000 shares of
common stock issued in 2001 for a period of one year. The warrants now expire in
April 2007.

         Subsequent to the period covered by this report the Company received
$166,000 from six accredited investors that purchased an aggregate of 415,000
shares of the Company's restricted common stock at $0.40 per share. The

                                       11
<PAGE>
issuances were exempt from registration under Section 4(2) of the Securities
Act. The investors received information concerning the Company and had the
opportunity to ask questions concerning the viability of the Company. The shares
contain legends restricting their transferability absent registration or
applicable exemption.

Item 3.  Default Upon Senior Securities

         None.

Item 4.  Submission of Matters to a Vote of Securities

         None.

Item 5.  Other Information

         None.

Item 6.  Exhibits

         Exhibits required by Item 601 of Regulation S-B

         31.1     Form 302 Certification of Chief Executive Officer
         31.2     Form 302 Certification of Principal Financial Officer
         32.1     Form 906 Certification of Chief Executive Officer and
                  Principal Financial Officer



































                                       12
<PAGE>
                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned as a duly authorized officer of the Registrant.

Enviro Voraxial Technology, Inc.


By: /s/ Alberto DiBella
    -------------------
    Alberto DiBella
    Chief Executive Officer and
    Principal Financial Officer

DATED:  May 19, 2006













































                                       13